Noho (DRNK) Return on Equity ROE from the third quarter 2014 to third quarter 2013 and annually, average high and low, overall ranking from Sep 30 2014 to Sep 30 2013 - CSIMarket
CSIMarket
 


Noho, Inc.  (DRNK)

Noho's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Noho in the third quarter 2014?
Due to the lack of equity, it was not possible to calculate Noho, Inc.'s return on equity (ROE) in its third quarter 2014

What is ROE?




Return On Equity (Sep 30 2014)
III. Quarter
(Jun 30 2014)
II. Quarter
(Mar 31 2014)
I. Quarter
(Dec 31 2013)
IV. Quarter
(Sep 30 2013)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -6 -5 -5 -3 -2
Return On Equity (TTM) - - - - -
DRNK's Total Ranking # # # # #
Equity (TTM) in Millions -3 -2 -2 -1 -1
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





DRNK Annual Return On Equity (Dec 31 2013)
2013
(Oct 31 2012)
2012



Total Equity in Millions -1 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -3 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -





More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
DRNK's' Return on Equity at Yahoo Finance
DRNK's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for DRNK's Competitors
Subscribers only: Roe for Noho's Suppliers
Subscribers only: Return On Equity for DRNK's Customers




Companies with similar Return On Equity at Sep 30 2014, within Healthcare Sector ROE
Gene Biotherapeutics Inc   247.35 %
Titan Pharmaceuticals Inc   236.40 %
Tuhura Biosciences Inc   199.17 %
Viskase Holdings inc   167.78 %
Arena Pharmaceuticals Inc   140.52 %
Brainstorm Cell Therapeutics inc   133.90 %
Eternity Healthcare Inc.  127.55 %
Aerie Pharmaceuticals Inc   125.13 %
Lifevantage Corp  107.34 %
Icagen, Inc.  99.25 %
Savara Inc   96.20 %
Bluebird Bio Inc   91.55 %
Bausch Health Companies Inc   87.84 %
Mirati Therapeutics Inc   78.88 %
Cymabay Therapeutics Inc   78.80 %
Abbvie Inc   77.93 %
Applied Genetic Technologies Corporation  77.91 %
Cyclo Therapeutics Inc   76.49 %
Evoke Pharma Inc   76.34 %
Seer Inc   74.59 %
Iveric Bio Inc   70.29 %
Gilead Sciences Inc   67.34 %
Bioage Labs Inc   65.34 %
Sophiris Bio Inc.  64.78 %
Sunwin Stevia International Inc.  64.29 %
Epizyme Inc.  61.60 %
Eyepoint Inc   56.78 %
Sonoma Pharmaceuticals Inc   56.46 %
Encompass Health Corporation  54.96 %
Acceleron Pharma inc  54.28 %


Date modified: 2026-09-08T15:21:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.